The Scottish Medicines Consortium has approved the use of GlaxoSmithKline’s Avamys (fluticasone furoate) - a once-daily nasal spray for the treatment of the symptoms of allergic rhinitis – on the ...
GlaxoSmithKline has been boosted by the news that European regulators have given the green light to the firm’s hay fever treatment Avamys. GlaxoSmithKline has been boosted by the news that European ...
LONDON, Jan 15 (Reuters) - GlaxoSmithKline , Europe's biggest drugmaker, said on Tuesday its once-daily treatment for allergic rhinitis, Avamys, had been approved by the European Commission. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback